Skip to content

MLPR As A Diagnostic Marker For Acute Pulmonary Embolism

Monocyte To Large Platelet Ratio As A Diagnostic Marker For Acute Pulmonary Embolism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07023705
Enrollment
53
Registered
2025-06-17
Start date
2024-01-01
Completion date
2025-05-31
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis, Pulmonary Embolism (Diagnosis)

Brief summary

A retrospective study to assess the utility of hematological marker (monocyte to large platelet ratio) to diagnose patients with pulmonary embolism

Detailed description

The investigators conducted a retrospective review of emergency department records of patients who presented with signs and symptoms suggestive of pulmonary embolism (PE) and underwent CT pulmonary angiography (CTPA) for diagnosis. Hematological laboratory findings obtained prior to any treatment were collected and compared between two groups based on CTPA results: those with confirmed PE (CT positive) and those without PE (CT negative).

Interventions

DIAGNOSTIC_TESTMonocyte to Large Platelet Ratio (MLPR)

Admission laboratory values were used to calculate the Monocyte-to-Large Platelet Ratio (MLPR) by dividing the absolute monocyte count by the large platelet count. These values were obtained from blood samples collected before any treatment was administered.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Only patients with the results of full blood count and white blood cell differentiation, measured before the treatment of suspected PE. * Patients underwent CT pulmonary angiography to confirm or exclude pulmonary embolism diagnosis.

Exclusion criteria

* Patient with history of any myeloproliferative disorder, myelofibrosis, Glanzmann thrombasthenia, May-Hegglin anomaly, Bernard-Soulier syndrome, suspicion of disseminated intravascular coagulation. * Patient receiving any anticoagulant drug at a therapeutic dose. * Patient with blood transfusion in the last 2 months. * Patients with acute coronary syndrome, pulmonary edema. * Patient on immunosuppressive drugs , Oral contraceptive pills . * Patients with severe renal or hepatic disease. * Patients with Stroke. * Patients with malignancy.

Design outcomes

Primary

MeasureTime frameDescription
Monocyte-to-Large Platelet Ratio (MLPR)At emergency department admission (baseline lab measurement) before any treatment.A ratio between monocyte absolute count and the large platelets count (MLPR) values compared between groups using Mann-Whitney U test; diagnostic accuracy evaluated by area under the curve (AUC) , sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).

Secondary

MeasureTime frameDescription
Mean platelet volume (MPV)At emergency department admission (baseline lab measurement) before any treatment.MPV values compared between groups using Mann-Whitney U test; diagnostic accuracy evaluated by AUC, sensitivity, specificity, PPV, and NPV.
Neutrophil to Lymphocyte Ratio (NLR)At emergency department admission (baseline lab measurement) before any treatment.The ratio between absolute neutrophil and absolute lymphocytes count (NLR) values compared between groups using Mann-Whitney U test; diagnostic accuracy evaluated by AUC, sensitivity, specificity, PPV, and NPV.
D-Dimer LevelsAt emergency department admission (baseline lab measurement) before any treatment.D-Dimer concentration values compared between groups using Mann-Whitney U test; diagnostic accuracy evaluated by AUC, sensitivity, specificity, PPV, and NPV.
Platelet Distribution Width (PDW)At emergency department admission (baseline lab measurement) before any treatment.PDW values compared between groups using Mann-Whitney U test; diagnostic accuracy evaluated by AUC, sensitivity, specificity, PPV, and NPV.
Platelet To Lymphocyte Ratio (PLR)At emergency department admission (baseline lab measurement) before any treatment.The ratio between total platelets count and absolute lymphocytes count (PLR) values compared between groups using Mann-Whitney U test; diagnostic accuracy evaluated by AUC, sensitivity, specificity, PPV, and NPV.

Countries

Egypt

Contacts

STUDY_CHAIRReem H Elkabarity, Professor

Ain Shams University

STUDY_DIRECTORHadil M Abdelhamid, Professor

Ain Shams University

STUDY_DIRECTORAzza Lotfy, Professor

Ain Shams University

PRINCIPAL_INVESTIGATORMohamed k Awad, Lecturer

Ain Shams University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026